Found: 12
Select item for more details and to access through your institution.
Factors influencing initial choice of insulin therapy in a large international non-interventional study of people with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 10, p. 901, doi. 10.1111/j.1463-1326.2012.01613.x
- By:
- Publication type:
- Article
Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea ( GetGoal-L-Asia) Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea ( GetGoal-L-Asia).
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 10, p. 910, doi. 10.1111/j.1463-1326.2012.01618.x
- By:
- Publication type:
- Article
Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic β-cell mass in a streptozotocin-induced mouse model of type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 10, p. 918, doi. 10.1111/j.1463-1326.2012.01619.x
- By:
- Publication type:
- Article
Patient-reported outcomes in trials of incretin-based therapies in patients with type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 10, p. 882, doi. 10.1111/j.1463-1326.2012.01595.x
- By:
- Publication type:
- Article
Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 10, p. 927, doi. 10.1111/j.1463-1326.2012.01620.x
- By:
- Publication type:
- Article
No pharmacokinetic interaction between ipragliflozin and sitagliptin, pioglitazone, or glimepiride in healthy subjects.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 10, p. 937, doi. 10.1111/j.1463-1326.2012.01624.x
- By:
- Publication type:
- Article
Two-week treatment with the β<sub>3</sub>-adrenoceptor antagonist SR59230A normalizes the increased pancreatic islet blood flow in type 2 diabetic GK rats.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 10, p. 960, doi. 10.1111/j.1463-1326.2012.01616.x
- By:
- Publication type:
- Article
Metformin therapy in patients with chronic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 10, p. 963, doi. 10.1111/j.1463-1326.2012.01617.x
- By:
- Publication type:
- Article
Effect of a long-term oral l-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 10, p. 893, doi. 10.1111/j.1463-1326.2012.01615.x
- By:
- Publication type:
- Article
11 β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 10, p. 869, doi. 10.1111/j.1463-1326.2012.01582.x
- By:
- Publication type:
- Article
Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 10, p. 944, doi. 10.1111/j.1463-1326.2012.01638.x
- By:
- Publication type:
- Article
Dapagliflozin monotherapy in drug-naïve patients with diabetes: a randomized-controlled trial of low-dose range.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 10, p. 951, doi. 10.1111/j.1463-1326.2012.01659.x
- By:
- Publication type:
- Article